UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): September 20, 2011
Express Scripts, Inc.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
|
| Delaware
|
|
0-20199
|
|
43-1420563 |
|
|
|
|
|
|
| (State or other jurisdiction
|
|
(Commission
|
|
(I.R.S. Employer |
| of incorporation)
|
|
File Number)
|
|
Identification No.) |
| |
|
|
|
| One Express Way, St. Louis, MO
|
|
63121 |
|
|
|
|
| (Address of principal executive offices)
|
|
(Zip Code) |
Registrant’s telephone number, including area code 314-996-0900
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
þ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 8.01.
On September 20, 2011, Express Scripts, Inc. (“Express Scripts”) and Medco Health Solutions, Inc.
(“Medco”) issued a joint press release announcing that Express Scripts Chairman and CEO, George Paz
and Medco Chairman and CEO, David B. Snow, Jr., appeared before the House Judiciary Subcommittee on
Intellectual Property, Competition and the Internet. The full text of the press release is filed
as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
| |
|
|
| Exhibit No. |
|
Description |
99.1
|
|
Joint Press Release, dated September 20, 2011. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused
this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| |
|
|
|
|
| |
Express Scripts, Inc.
(Registrant)
|
|
| |
By: |
/s/ Keith Ebling
|
|
| |
|
Name: |
Keith Ebling |
|
| |
|
Title: |
Executive Vice President and
General Counsel |
|
| |
Dated: September 20, 2011
3